獸醫輔助生殖技術市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024年，全球獸醫輔助生殖技術市場規模達79億美元，預計2034年將以8.2%的複合年成長率成長，達到170億美元。這一成長主要源於牲畜存欄量的增加、肉類和乳製品需求的不斷成長以及畜牧業投資的增加。隨著牲畜育種和基因改良對滿足全球糧食需求的重要性日益凸顯，獸醫輔助生殖技術（ART）正被用於提高繁殖效率、改善畜群遺傳學和整體生產力。透過利用優良遺傳材料並縮短育種週期，ART有助於提高牛奶和肉類的產量，從而促進全球消費的成長。

在許多國家，政府以補貼和畜牧業計畫的形式提供支持，進一步推動了抗逆轉錄病毒療法（ART）技術的採用。此外，包括冷凍保存、卵子提取（OPU）和精準育種在內的持續技術進步，也提高了抗逆轉錄病毒療法的可及性，使小型診所和大型農場都能從這些技術中受益。獸醫抗逆轉錄病毒療法在動物育種、瀕危物種保護和牲畜健康改善方面發揮著至關重要的作用。

2024年，精液市場價值達26億美元。精液在人工授精（AI）中至關重要，由於其能夠改善畜群遺傳特性並避免與自然交配相關的疾病，已成為選擇性育種計劃中不可或缺的一部分。採用基於精液的輔助生殖技術（ART）策略，農民和育種者能夠提高牲畜的生產力和獲利能力。冷凍保存和精液性別鑑定技術的最新進展使得獲得更好的育種效果成為可能，而精液品質檢測和配送物流的創新則鞏固了該領域的市場地位。此外，教育計畫、財政激勵措施以及獸醫服務的日益普及也支持了基於精液的輔助生殖技術在該行業的廣泛應用。

預計到2034年，人工授精 (AI) 市場規模將達到127億美元。 AI廣泛應用於各種動物，尤其是在畜牧業和乳製品行業，因為它能夠更有效地安排配種時間，減少對多頭雄性種畜的需求，並將基因優良雄性種畜的繁殖範圍擴大到偏遠地區。該技術增強了畜群遺傳學，提高了生產力，增強了抗病能力，所有這些都使其得到了廣泛的認可。與自然繁殖相比，AI也被認為更具成本效益和可靠性，並且受傷和疾病傳播的風險更低，使其成為農民和育種者的首選。旨在提高畜牧業生產力的政府和非政府計畫進一步加速了AI技術的普及。

2024年，美國獸醫輔助生殖技術市場規模達25億美元。由於其完善的獸醫醫療基礎設施和先進生殖技術的廣泛應用，美國在全球獸醫輔助生殖技術市場中佔據重要地位。美國的獸醫診所配備了最先進的設施，可執行人工授精、胚胎移植和體外受精等輔助生殖技術（ART）程序。商業化育種機構擴大利用ART技術來改善遺傳品質和控制疾病，從而改善畜群健康狀況。此外，美國強大的供應商和服務提供者網路提高了ART產品和服務的可近性，從而推動了市場成長。

全球獸醫輔助生殖技術市場的主要參與者包括 Minitube Group、IMV Technologies、Genus Plc、CRV Holdings、Bovine Elite、Select Sires、STgenetics、SEMEX、Swine Genetics International、Geno SA、VikingGenetics 和 URUS Group。在策略方面，獸醫輔助生殖技術市場中的公司專注於擴大產品組合併增強服務內容，以鞏固其市場地位。關鍵策略包括開發創新解決方案，例如先進的精液冷凍保存技術、胚胎移植技術和精準育種工具。與研究機構和獸醫診所的合作也在提高輔助生殖技術服務的可及性和有效性方面發揮著重要作用，尤其是在新興市場。公司也大力投資教育項目，為獸醫專業人員提供培訓計劃，以提高這些技術的整體應用率。此外，一些公司專注於地理擴張，瞄準牲畜數量不斷成長、肉類和乳製品需求不斷成長的地區，例如亞太地區和拉丁美洲。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
  • 供應商格局
  • 每個階段的增值
  • 影響價值鏈的因素
• 產業衝擊力
  • 成長動力
    • 動物養殖需求不斷成長
    • 獸醫學的進步
    • 注重基因保存
    • 獸醫保健支出增加
  • 產業陷阱與挑戰
    • 先進生殖技術相關的高昂初始設定成本
    • 手術失敗和併發症的風險
  • 市場機會
    • 基因組選擇與精準育種的整合
    • 保護和瀕危物種繁殖的需求不斷成長
• 成長潛力分析
• 監管格局
• 技術格局
  • 當前的技術趨勢
  • 新興技術
• 未來市場趨勢
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按類型，2021 - 2034 年

• 主要趨勢
• 服務
• 精液
  • 正常精液
  • 性控精液
• 儀器
• 套件和耗材

第6章：市場估計與預測：按技術，2021 - 2034 年

• 主要趨勢
• 人工授精（AI）
• 體外受精（IVF）
• 胚胎移植（MOET）
• 其他技術

第7章：市場估計與預測：按動物類型，2021 - 2034 年

• 主要趨勢
• 牛
• 豬
• 綿羊
• 山羊
• 馬
• 其他動物類型

第8章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 獸醫診所和醫院
• 動物養殖中心
• 科學研究院所及大學
• 其他最終用途

第9章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 波蘭
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• Bovine Elite
• CRV Holdings
• Geno SA
• Genus Plc
• IMV Technologies
• Minitube Group
• SEMEX
• Select Sires
• Swine Genetics International
• STgenetics
• URUS Group
• VikingGenetics

The Global Veterinary Assistive Reproduction Technology Market was valued at USD 7.9 billion in 2024 and is estimated to grow at a CAGR of 8.2% to reach USD 17 billion by 2034. This growth is primarily driven by the rising livestock population, an increasing demand for meat and dairy products, and greater investments in the livestock sector. As breeding and genetic improvement in livestock animals become more critical to meeting global food demand, veterinary ART technologies are being adopted to improve reproductive efficiency, herd genetics, and overall productivity. By leveraging superior genetic materials and enhancing breeding cycles, ART helps to boost yields of milk and meat, which in turn supports rising global consumption.

In many countries, governmental support in the form of subsidies and livestock programs further drives the adoption of ART technologies. Additionally, ongoing technological advancements, including cryopreservation, ovum pick-up (OPU), and precision breeding, are improving accessibility to ART, enabling small clinics and large farms alike to benefit from these technologies. Veterinary ART plays an essential role in animal breeding, the conservation of endangered species, and the improvement of livestock health.

The semen segment was valued at USD 2.6 billion in 2024. Semen is crucial in artificial insemination (AI) and has become an integral part of selective breeding programs due to its ability to improve herd genetics and avoid diseases associated with natural mating. The adoption of semen-based ART strategies enables farmers and breeders to enhance livestock productivity and profitability. Recent advancements in cryopreservation and semen sexing technologies have made it possible to achieve better breeding results, and innovations in semen quality testing and distribution logistics have bolstered the segment's market position. Furthermore, educational programs, financial incentives, and the growing availability of veterinary services are also supporting the widespread use of semen-based ART in the industry.

Artificial insemination (AI) segment is expected to reach USD 12.7 billion by 2034. AI is widely used in various animal species, particularly in livestock and dairy sectors, for its ability to schedule breeding more effectively, reduce the need for multiple male breeding animals, and extend the reach of genetically superior males to remote locations. The technology has enhanced herd genetics, improved productivity, and increased disease resistance, all of which have led to its widespread acceptance. AI is also considered more cost-effective, and reliable, and carries a lower risk of injury and disease transmission compared to natural breeding, making it a preferred option for farmers and breeders. Government and non-governmental programs designed to boost livestock productivity further accelerate the adoption of AI technologies.

U.S. Veterinary Assistive Reproduction Technology Market was valued at USD 2.5 billion in 2024. The country is a key player in the global veterinary assistive reproduction technology market, driven by a sophisticated veterinary healthcare infrastructure and high adoption of advanced reproductive technologies. Veterinary clinics in the U.S. are equipped with state-of-the-art facilities to perform ART procedures such as AI, embryo transfer, and in vitro fertilization. Commercial breeding operations are increasingly utilizing ART to improve genetic quality and control diseases, leading to better herd health. Additionally, a strong network of suppliers and service providers in the U.S. increases accessibility to ART products and services, propelling market growth.

Key players in the Global Veterinary Assistive Reproduction Technology Market include Minitube Group, IMV Technologies, Genus Plc, CRV Holdings, Bovine Elite, Select Sires, STgenetics, SEMEX, Swine Genetics International, Geno SA, VikingGenetics, and URUS Group. In terms of strategies, companies in the veterinary assistive reproduction technology market focus on expanding their product portfolios and enhancing service offerings to strengthen their market position. Key strategies include developing innovative solutions such as advanced semen cryopreservation techniques, embryo transfer technologies, and precision breeding tools. Partnerships with research institutions and veterinary clinics also play a significant role in increasing the accessibility and effectiveness of ART services, especially in emerging markets. Companies are also investing heavily in educational initiatives, providing training programs for veterinary professionals to improve the overall adoption of these technologies. Furthermore, some companies are focusing on geographical expansion by targeting regions with growing livestock populations and rising demand for meat and dairy products, such as Asia-Pacific and Latin America.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Type
  • 2.2.3 Technology
  • 2.2.4 Animal type
  • 2.2.5 End use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factors affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising demand for animal breeding
    • 3.2.1.2 Advancements in veterinary medicine
    • 3.2.1.3 Focus on genetic preservation
    • 3.2.1.4 Increasing veterinary healthcare expenditure
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High initial setup costs associated with advanced reproductive technologies
    • 3.2.2.2 Risk of procedural failures and complications
  • 3.2.3 Market opportunities
    • 3.2.3.1 Integration of genomic selection and precision breeding
    • 3.2.3.2 Rising demand for conservation and endangered species breeding
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Services
• 5.3 Semen
  • 5.3.1 Normal semen
  • 5.3.2 Sexed semen
• 5.4 Instruments
• 5.5 Kits and consumables

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Artificial insemination (AI)
• 6.3 In vitro fertilization (IVF)
• 6.4 Embryo transfer (MOET)
• 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Bovine
• 7.3 Swine
• 7.4 Ovine
• 7.5 Caprine
• 7.6 Equine
• 7.7 Other animal types

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary clinics and hospitals
• 8.3 Animal breeding centers
• 8.4 Research institutes and universities
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Poland
  • 9.3.7 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Bovine Elite
• 10.2 CRV Holdings
• 10.3 Geno SA
• 10.4 Genus Plc
• 10.5 IMV Technologies
• 10.6 Minitube Group
• 10.7 SEMEX
• 10.8 Select Sires
• 10.9 Swine Genetics International
• 10.10 STgenetics
• 10.11 URUS Group
• 10.12 VikingGenetics